Infections specific to the perinatal period

P16_INFECTIONS_SPECIFIC_PERINA_PERIOD

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — P35-P39 Cause of death: ICD-10 — P35-P39 2 out of 7 registries used, show all original rules.	436
4. Check minimum number of events None	436
5. Include endpoints P16_CONGN_VIRAL_DISEA P16_BACTERIAL_SEPSIS_NEWBO P16_OTH_CONGN_INFECTIOUS_PARASITIC_DISEA P16_OMPHA_NEWBO_W_WO_MILD_HAEMORRHAGE P16_OTH_INFECTIONS_SPECIFIC_PERINA_PERIOD	436
6. Filter based on genotype QC (FinnGen only)	436

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: P
Name in latin: Infectiones temporis perinatalis specificae

NAME	P16_INFECTIONS_SPECIFIC_PERINA_PERIOD
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	P16_CONGN_VIRAL_DISEA\|P16_BACTERIAL_SEPSIS_NEWBO\|P16_OTH_CONGN_INFECTIOUS_PARASITIC_DISEA\|P16_OMPHA_NEWBO_W_WO_MILD_HAEMORRHAGE\|P16_OTH_INFECTIONS_SPECIFIC_PERINA_PERIOD
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	P3
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	P3
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Infections specific to the perinatal period based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	42413	17614	24798
Only index persons	19844	8095	11749
Unadjusted period prevalence (%)
Whole population	0.61	0.50	0.69
Only index persons	0.39	0.30	0.45
Median age at first event (years)
Whole population	0.00	0.00	0.00
Only index persons	0.00	0.00	0.00

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	436	246	190
Unadjusted period prevalence (%)	0.08	0.08	0.08
Median age at first event (years)	0.00	0.00	0.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
383: Matched controls
3828

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

P39.9

ICD-10 Finland

Infection specific to the perinatal period, unspecified

+∞

157.5

140

P36.90

ICD-10 Finland

Suspected bacterial sepsis of newborn

+∞

144.1

129

P39.1

ICD-10 Finland

Neonatal conjunctivitis and dacryocystitis

+∞

23.2

P36.0

ICD-10 Finland

Sepsis of newborn due to streptococcus, group B

+∞

21.0

P36.99

ICD-10 Finland

Bacterial sepsis of newborn, unspecified

+∞

20.0

Z87.6

ICD-10 Finland

Personal history of certain conditions arising in the perinatal period

5.1

19.0

142

P01.10

ICD-10 Finland

Fetus and newborn affected by premature rupture of membranes 1-7 days before delivery

21.3

18.0

P22.1

ICD-10 Finland

Transient tachypnoea of newborn

7.6

15.0

P07.3

ICD-10 Finland

Other preterm infants

4.5

14.5

132

P39.4

ICD-10 Finland

Neonatal skin infection

+∞

11.5

P36.3

ICD-10 Finland

Sepsis of newborn due to other and unspecified staphylococci

+∞

10.5

P22.0

ICD-10 Finland

Respiratory distress syndrome of newborn

9.5

10.1

P39.0

ICD-10 Finland

Neonatal infective mastitis

+∞

9.4

P02.7

ICD-10 Finland

Fetus and newborn affected by chorioamnionitis

+∞

9.4

P22.9

ICD-10 Finland

Respiratory distress of newborn, unspecified

6.0

7.0

P21.1

ICD-10 Finland

Mild and moderate birth asphyxia

7.6

6.5

P38

ICD-10 Finland

Omphalitis of newborn with or without mild haemorrhage

71.0

6.4

ZX198

NOMESCO Finland

Other local administration

9.5

6.3

P59.0

ICD-10 Finland

Neonatal jaundice associated with preterm delivery

4.7

6.1

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023368) Bacteria identified in Blood by Culture

504

1.72

4.30

5.0

4.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

2.84

3.90

3.4

4.4

32.3

22.3

umol/l

1.06

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.05

2.58

1.1

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.05

2.58

1.1

1.2

—

(40768795) Lymph node Pathology biopsy report

4.66

2.27

1.0

1.1

—

(3020891) Body temperature

2.38

2.24

3.5

7.8

—

(3036048) Francisella tularensis Ab [Titer] in Serum

5.60

2.22

1.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

308

1.59

2.19

2.4

2.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

3.37

2.19

1.3

1.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

309

1.58

2.17

2.2

2.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.72

2.16

1.0

1.1

—

(3025159) Blasts/100 leukocytes in Blood

184

1.74

2.10

5.2

5.9

0.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

4.04

2.04

1.2

17.6

18.4

umol/l

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

360

3362

1.41

1.96

12.1

10.3

22.6

22.7

mg/l

0.01

244

2237

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

1.90

0.0

1.0

—

(3024928) Oxygen saturation in Venous blood

2.02

1.87

19.8

14.0

—

(3017181) Myelocytes/100 leukocytes in Blood

199

1.66

1.86

5.4

5.8

0.6

0.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

3.56

1.84

1.2

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

3.56

1.84

1.2

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

3.56

1.84

1.2

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

398

1.47

1.83

2.4

2.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.79

1.80

1.0

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1.97

1.77

1.5

2.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

118

1.82

1.73

2.3

2.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2.70

1.73

1.3

2.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.70

1.73

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

2.41

1.68

1.2

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

2.41

1.68

1.1

1.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

625

1.36

1.68

3.4

3.7

4.1

3.6

e6/l

0.11

353

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

134

1113

1.29

1.67

4.4

4.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

3.19

1.66

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

3.19

1.66

1.0

—

(3002179) Metamyelocytes/100 leukocytes in Blood

182

1.64

1.65

5.6

5.2

0.7

0.4

—

(3023419) Bacteria identified in Sputum by Culture

3.60

1.62

2.2

22.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

392

1.43

1.60

1.7

1.4

17.1

18.7

nmol/l

0.51

343

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

3.03

1.58

2.2

1.6

32.3

31.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

291

1.49

1.57

2.1

2.4

6.6

5.4

u/l

0.69

188

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

169

1456

1.26

1.55

13.5

11.8

1.2

mmol/l

0.06

161

1387

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

110

900

1.30

1.53

2.9

3.1

—

(4010399)

179

1.60

1.49

1.6

1.5

—

(3018418) pH of Serum or Plasma

637

1.33

1.49

4.7

4.1

7.4

—

114

(3029937) Albumin [Presence] in Urine by Test strip

637

1.33

1.49

3.1

3.5

0.0

estimate

0.00

231

(3019230) Fractional oxyhemoglobin in Venous blood

1.91

1.46

15.9

16.1

72.4

70.8

0.15

(3035350) Ketones [Presence] in Urine by Test strip

154

1322

1.25

1.44

3.4

3.3

0.0

estimate

0.00

228

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.75

1.44

1.3

1.0

—

(3000492) Spirometry study

240

1.50

1.39

1.6

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

153

1317

1.25

1.39

5.1

4.8

0.0

estimate

0.00

240

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.63

1.37

1.3

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

2.63

1.37

1.2

0.4

nmol/l

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.96

1.36

1.0

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

192

1.55

1.35

5.5

5.9

0.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

174

1524

1.24

1.35

12.7

11.1

1.2

mmol/l

0.49

160

1393

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

2.15

1.34

2.1

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

161

1.59

1.31

3.6

4.1

—

(3009261) Glucose [Presence] in Urine by Test strip

153

1326

1.24

1.30

3.5

3.4

0.0

estimate

0.00

235

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

623

1.31

1.30

3.5

3.6

0.4

0.9

e6/l

1.92

352

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

122

1.67

1.29

2.4

2.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

316

2955

1.25

1.29

15.2

11.6

3.9

mmol/l

0.07

309

2845

(3021589) Normoblasts [#/volume] in Blood

212

1902

1.22

1.29

9.2

10.6

0.0

e9/l

0.48

164

1444

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

123

1042

1.25

1.28

7.2

7.7

19.5

20.0

umol/l

0.05

110

946

(3030467) Casts [#/volume] in Urine by Automated count

118

997

1.25

4.2

0.3

0.2

e6/l

0.20

754

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.42

1.24

1.5

3.0

1.0

1.1

umol/l

—

(3020630) Protein [Mass/volume] in Serum or Plasma

108

1.69

1.24

1.3

3.7

63.7

g/l

0.01

100

(3002256) Pathology report gross observation

214

1.48

1.22

1.0

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

741

1.27

1.19

3.3

3.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1.73

1.19

1.3

2.1

—

(40761535) Cells panel - Urine sediment

134

1.60

1.16

3.6

3.9

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

1.16

0.0

1.2

—

33.4

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.00

1.16

0.0

1.2

—

18.5

—

(3000991) Gas panel - Venous blood

679

1.27

1.16

8.6

10.7

—

(40761536) Microorganisms panel - Urine sediment

225

1.46

1.16

2.7

3.6

—

(4034850)

2.07

1.15

6.6

8.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.52

1.15

1.0

1.2

—

(44790047)

1.71

1.15

2.6

2.2

—

(44790049)

1.71

1.15

2.6

2.2

—

(44806118)

1.71

1.15

2.6

2.2

—

(44790048)

1.71

1.15

2.6

2.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

757

1.25

1.11

3.7

2.6

2.4

mmol/l

0.40

694

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

2.28

1.10

1.0

—

(3022313) Gas panel - Capillary blood

619

1.28

1.10

9.1

9.0

—

(42870588) Differential panel, method unspecified - Blood

173

1540

1.20

1.10

8.3

9.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1.84

1.10

1.8

1.6

4.0

5.0

iu/l

—

(3002582) Erythrocytes [#/volume] in Urine

123

1059

1.22

1.10

4.4

25.2

22.1

e6/l

0.11

813

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.40

1.09

1.0

1.2

—

(3021788) Differential panel - Synovial fluid

2.40

1.09

1.2

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

2.40

1.09

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.40

1.09

1.0

1.2

—

(3015736) pH of Urine

124

1069

1.22

1.09

3.4

3.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

2.21

1.08

1.0

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

121

0.49

1.07

1.2

1.1

—

7.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

2.14

1.06

1.1

1.5

—

(40768441) Liver Pathology biopsy report

2.14

1.06

2.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

197

1780

1.19

1.05

6.9

5.4

125.6

120.6

u/l

0.34

181

1664

(3000494) Fungus identified in Specimen by Culture

273

1.39

1.05

1.6

2.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

314

2961

1.22

1.04

15.2

11.6

139.4

139.5

mmol/l

0.18

307

2870

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

104

885

1.23

1.03

3.0

3.4

2.6

2.7

mg/l

0.27

790

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.29

1.03

1.0

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.29

1.03

1.0

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.29

1.03

1.0

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

2.07

1.03

1.1

1.0

—

(36304419) Bacteria [Presence] in Urine

117

1009

1.22

1.02

4.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

157

0.56

1.00

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

499

1.28

0.99

1.8

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

250

1.39

0.99

2.2

2.0

207.8

169.4

u/ml

0.31

110

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

303

1.35

0.98

1.3

306.8

136.5

iu/ml

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.97

0.0

1.2

—

(3019150) Specific gravity of Urine by Refractometry

649

1.25

0.96

2.8

2.9

1.0

kg/l

1.99

106

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.67

0.95

2.3

1.8

—

(3044290) Cell count panel - Cerebral spinal fluid

102

1.59

0.91

4.8

5.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

254

1.37

0.91

2.2

2.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

478

1.27

0.91

1.9

1.6

—

(4268621)

2.08

0.89

2.0

2.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.08

0.89

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.92

0.89

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1.80

0.88

1.1

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1.80

0.88

2.2

2.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

657

1.23

0.86

2.9

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

145

1.47

0.86

1.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.83

0.86

1.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1095

0.83

0.86

5.3

4.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

138

1538

0.85

1.7

1.8

0.8

3.2

u/ml

2.80

287

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

322

3068

1.19

0.84

8.9

8.3

26.1

24.2

u/l

0.79

308

2958

(4035726)

163

1.43

0.83

1.8

1.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

484

1.25

0.83

4.1

4.9

5.4

1.3

mg/l

0.52

337

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

105

1.54

0.82

2.4

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.59

0.82

1.2

3.8

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

1.71

0.81

6.0

8.8

2.7

2.4

mg/l

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

709

1.21

0.81

11.2

9.0

1.0

mmol/l

0.08

494

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.00

0.79

0.0

2.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

3.7

—

230.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1.83

0.79

1.2

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

268

0.70

0.79

1.2

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1.68

0.79

1.9

1.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

140

1.45

0.78

3.7

2.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

107

1.51

0.77

4.7

4.9

3.5

3.3

mmol/l

0.59

102

(3024731) MCV [Entitic volume]

396

3859

1.29

0.77

18.0

14.8

86.2

86.0

0.18

390

3781

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.77

0.76

2.0

1.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.77

0.76

9.3

7.9

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.76

0.0

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

2.09

0.74

1.2

2.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

2.09

0.74

1.0

1.1

—

(3035941) MCH [Entitic mass]

396

3861

1.28

0.74

18.0

14.8

28.9

0.19

390

3786

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.85

0.74

1.0

—

(3018095) Leukocytes [#/volume] in Urine

139

1252

1.16

0.73

5.4

5.0

45.3

56.0

e6/l

0.18

845

(3026361) Erythrocytes [#/volume] in Blood

396

3862

1.28

0.73

18.0

14.8

4.6

e12/l

0.46

372

3663

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.01

0.73

1.6

1.9

1.4

1.6

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.01

0.73

1.6

1.9

1.4

7.6

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.01

0.73

1.6

1.9

2.5

5.3

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.01

0.73

1.6

1.9

0.5

1.1

mg/l

—

(3045142) Bone marrow Pathology biopsy report

1.81

0.72

1.3

1.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.81

0.72

2.0

1.3

—

(40761511) CBC panel - Blood by Automated count

348

3353

1.19

0.72

9.3

7.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

191

1763

1.15

0.72

3.0

2.7

2.6

mmol/l

0.21

182

1648

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

177

1.38

0.72

2.7

2.2

—

(3022145) Colonoscopy Study observation

160

1.39

0.71

1.5

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.76

0.71

2.0

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1.76

0.71

6.6

9.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.59

0.71

1.3

1.4

—

(40758558) Short blood count panel - Blood

128

1149

1.16

0.71

6.7

9.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.93

0.71

1.0

1.6

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.93

0.71

1.6

2.0

1.4

1.0

mg/l

—

(3002385) Erythrocyte distribution width [Ratio]

337

3241

1.17

0.70

17.4

14.3

13.3

13.1

1.98

329

3176

(3047007) Chlamydophila sp Ab [Presence] in Serum

146

0.61

0.70

1.2

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

284

0.73

0.70

1.0

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.72

0.70

9.7

10.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.56

0.70

2.6

2.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

396

3866

1.27

0.69

18.3

15.0

132.6

133.5

g/l

0.65

390

3796

(3010813) Leukocytes [#/volume] in Blood

396

3866

1.27

0.69

18.0

14.8

6.8

6.7

e9/l

0.12

373

3673

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

505

1.22

0.69

1.9

1.7

1.6

1.2

mmol/l

0.51

468

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1.61

0.69

1.7

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.86

0.68

1.0

1.5

—

(3007461) Platelets [#/volume] in Blood

395

3856

1.26

0.68

18.1

14.9

274.8

270.7

e9/l

0.54

370

3673

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

167

1809

0.87

0.67

2.2

2.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.64

0.67

4.3

5.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

666

1.19

0.67

1.8

1.5

98.9

pmol/l

0.00

352

(3023410) Appearance of Cerebral spinal fluid

1.53

0.66

5.7

6.0

—

(1002224) Polysomnography panel

1.79

0.66

1.4

1.1

—

(40768804) Tissue Pathology biopsy report

671

0.83

0.65

1.6

1.7

—

(40768446) Kidney Pathology biopsy report

1.60

0.65

2.6

2.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

252

1.29

0.64

1.6

1.4

567.2

29911146.1

pmol/l

0.50

224

(3002032) Base excess in Venous blood by calculation

747

1.17

0.62

9.8

9.4

0.0

1.2

mmol/l

1.40

581

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1.67

0.61

4.0

1.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.00

0.60

0.0

2.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.57

0.59

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

180

1674

1.13

0.58

2.9

2.6

1.2

1.1

mmol/l

0.82

172

1580

(4027681)

1.72

0.58

1.3

1.2

—

(3019060) Gas panel - Arterial blood

1.49

0.57

7.1

2.6

—

(21494434) Karyotype in Bone marrow

1.67

0.57

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

1.52

0.56

1.2

2.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.46

0.56

1.4

—

(3005033) Fetal Nuchal fold Thickness US

1.46

0.56

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.63

0.55

2.0

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

230

2177

1.12

0.54

10.1

10.4

3.3

3.4

e9/l

0.74

190

1821

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.59

0.54

8.3

7.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.59

0.54

8.3

6.8

—

(3011288) Drugs identified in Urine by Screen method

324

1.22

0.53

1.3

2.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

179

1.30

0.52

1.7

1124.9

1102.0

nmol/l

0.04

134

(40760892) CBC W Ordered Manual Differential panel - Blood

701

1.15

0.52

5.4

5.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

213

0.74

0.51

1.2

1.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

1.48

0.51

2.9

4.9

—

(3020874) Milk IgE Ab [Units/volume] in Serum

118

1.37

0.50

1.1

1.4

0.8

3.4

u/ml

1.29

(3023323) Follitropin [Units/volume] in Serum or Plasma

271

1.23

0.50

2.0

2.4

4.5

7.7

iu/l

2.85

182

(3014148) Varicella zoster virus Ab [Titer] in Serum

107

0.65

0.49

1.0

1.2

—

(3018010) Neutrophils/100 leukocytes in Blood

213

2017

1.11

0.48

8.0

8.8

49.0

49.6

0.28

208

1927

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.48

0.47

2.6

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

320

1.20

0.46

5.3

5.0

62.1

62.0

e9/l

0.00

201

(3025018) Bordetella pertussis Ab [Titer] in Serum

119

0.67

0.46

1.3

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

167

1565

1.11

0.46

3.9

3.1

36.6

36.3

mmol/mol

0.12

158

1468

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

190

1794

1.10

0.45

3.1

2.8

4.3

mmol/l

0.04

182

1705

(3012516) Albumin [Mass/volume] in Urine

266

1.22

0.44

3.8

57.3

93.5

mg/l

0.50

212

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.63

0.42

1.0

18.5

19.2

mmol/l

—

(3006598) pH of Arterial cord blood

0.63

0.42

1.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

361

1.18

0.42

5.0

3.2

1229.9

1407.8

ng/l

0.08

202

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

282

0.80

0.42

1.4

1.3

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.41

0.0

2.6

—

3.8

—

(3032641) Amino acids panel - Urine

0.00

0.41

0.0

1.1

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.41

0.0

4.7

—

4.6

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

0.41

0.0

6.4

—

44.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

1164.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.41

0.0

2.1

—

(3022621) pH of Urine by Test strip

138

0.72

0.41

3.1

2.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

647

1.13

0.41

2.1

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.00

0.40

0.0

1.6

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

288

1.20

0.40

12.1

9.7

105.0

105.5

mmol/l

0.30

283

(3014765) Yersinia sp identified in Stool by Organism specific culture

101

0.69

0.40

1.3

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

102

0.68

0.40

1.3

1.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

216

2063

1.09

0.39

8.3

8.9

35.9

35.0

0.56

210

1966

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.00

0.39

0.0

5.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

124

1.30

0.39

1.3

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

124

1.30

0.39

1.3

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

1.38

0.38

1.5

2.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.39

0.38

1.8

1.3

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.39

0.38

1.0

1.6

168.8

118.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.39

0.38

1.0

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1.36

0.38

1.4

2.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

184

1747

1.09

0.38

3.0

2.7

1.4

mmol/l

0.86

175

1646

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

1.34

0.37

2.3

4.4

26.0

26.1

0.02

(3026782) Osmolality of Urine

690

1.12

0.37

2.9

3.4

510.4

610.3

mosm/kgh2o

2.69

602

(3013336) Amino acids [Identifier] in Serum or Plasma

1.35

0.37

3.8

2.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

221

2117

1.09

0.37

4.3

4.4

8.9

6.9

mm/h

1.19

207

1968

(44813793)

1.29

0.37

1.0

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.47

0.36

1.0

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1.32

0.35

1.2

199.8

314.4

iu/ml

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.43

0.35

1.8

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1.43

0.35

3.5

1.5

—

(3019225) pH of Specimen

117

1.29

0.35

1.9

4.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

265

1.18

0.34

5.2

4.4

6.0

9.0

mg/mmol

0.33

215

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

256

1.18

0.34

3.0

1.8

2.4

mmol/l

0.28

210

(3001604) Monocytes [#/volume] in Blood

212

2033

1.08

0.34

8.1

9.0

0.6

e9/l

0.11

177

1698

(3000093) Morphology [Interpretation] in Blood Narrative

1.34

0.34

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

1012

0.91

0.33

1.8

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

783

1.11

0.33

14.9

12.9

24.7

mmol/l

0.01

783

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.67

0.33

1.2

1.1

—

(3032080) INR in Blood by Coagulation assay

658

1.11

0.32

5.9

4.3

1.1

inr

0.75

197

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.31

0.32

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

362

1.15

0.31

2.7

2.3

16801.8

7894.1

u/l

—

108

(3006504) Eosinophils/100 leukocytes in Blood

205

1968

1.08

0.31

8.5

9.1

2.9

3.2

0.88

200

1869

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.72

0.31

1.3

1.1

—

(3011648) Oxygen content in Venous blood

1.33

0.31

32.1

20.0

11.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

439

1.13

0.31

2.2

2.7

374.0

351.1

nmol/l

0.34

420

(3045414) Leukocytes [Presence] in Urine

100

0.69

0.31

3.4

1.6

—

(3016879) Cocaine [Presence] in Urine

449

1.13

0.30

1.2

1.7

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.34

0.30

1.1

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

217

2090

1.08

0.30

8.0

8.9

2.3

e9/l

0.16

187

1798

(3006245) CD3-CD19+ cells/100 cells in Blood

111

1.27

0.30

2.4

4.6

16.9

17.7

0.08

111

(3037467) Urinalysis macro (dipstick) panel - Urine

200

1921

1.08

0.30

4.6

4.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

141

0.77

0.30

1.1

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

185

1.20

0.29

1.2

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

1.25

0.29

6.3

4.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

157

1496

1.08

0.29

3.7

4.3

27.5

26.2

u/l

0.20

144

1438

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

396

0.87

0.29

1.1

1.2

—

3.3

—

(3037522) Nuclear Ab [Titer] in Serum

448

0.88

0.28

1.6

592.0

524.4

titre

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

261

1.16

0.28

1.7

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

290

0.85

0.28

1.6

1.4

—

(3042936) Bacteria identified in Isolate by Culture

311

0.86

0.28

4.4

1.9

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.28

0.28

1.2

1.4

—

(1761868) Lipid panel - Serum or Plasma

548

1.11

0.28

2.3

1.8

—

(3019069) Monocytes/100 leukocytes in Blood

206

1985

1.07

0.28

8.9

9.2

8.4

8.3

0.33

201

1885

(3009542) Hematocrit [Volume Fraction] of Blood

356

3499

1.09

0.27

16.4

13.1

39.3

39.4

0.26

307

3077

(3006315) Basophils [#/volume] in Blood

211

2037

1.07

0.27

8.1

9.0

0.0

e9/l

1.09

177

1702

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

104

1.26

0.26

2.3

4.4

10.2

8.1

0.72

(1175426) CD3 cells/100 lymphocytes in Blood

104

1.26

0.26

2.3

4.4

67.6

68.0

0.04

104

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

178

1.19

0.26

1.4

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

0.69

0.26

1.0

1.2

—

4.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.68

0.26

1.0

1.2

—

14.9

—

(3014007) Fractional oxyhemoglobin in Arterial blood

123

1.23

0.25

12.1

14.0

93.0

95.7

0.34

123

(36660697) Celiac disease serology panel - Serum

640

0.91

0.25

1.3

1.2

—

(1616796) Gas panel - Central venous blood

1.20

0.25

2.6

5.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

148

0.81

0.25

8.2

5.8

111.8

177.5

ng/l

0.54

139

(3026008) Bacteria identified in Urine by Culture

737

1.09

0.25

3.0

2.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

1.27

0.24

2.8

5.9

92.9

93.8

0.04

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

0.73

0.24

1.2

1.6

2.8

6.2

ug/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

197

1904

1.06

0.23

2.5

2.2

5.5

5.3

mmol/l

0.72

175

1728

(3047181) Lactate [Moles/volume] in Blood

1.28

0.23

10.8

2.6

1.1

1.3

mmol/l

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.28

0.23

1.0

1.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

174

1677

1.06

0.23

3.9

3.3

57.7

46.5

ug/l

0.39

165

1587

(3035933) Granulocytes/100 leukocytes in Blood

0.74

0.22

1.6

1.4

—

(3013512) EKG study

382

1.11

0.22

2.5

2.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

124

0.80

0.22

1.0

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.19

0.21

3.0

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1.19

0.21

4.2

3.0

62.2

56.5

umol/l

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1.19

0.21

3.6

2.8

35.0

54.0

u/ml

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

171.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.21

0.0

17.0

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

17.1

—

26.4

—

(3010503) CD19 cells [#/volume] in Blood

0.00

0.21

0.0

2.7

—

0.3

—

(3034426) Prothrombin time (PT)

0.00

0.21

0.0

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

0.00

0.21

0.0

1.4

—

10311.8

—

(3045788) Cell count panel - Pleural fluid

0.00

0.21

0.0

1.6

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

126

1.20

0.21

14.5

9.0

22.6

23.1

mmol/l

0.34

115

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.25

0.20

1.2

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.25

0.20

1.0

5.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.25

0.20

1.0

5.2

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.20

0.0

2.7

—

106.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.20

0.0

2.7

—

(3002619) Bacteria identified in Specimen by Culture

0.00

0.20

0.0

1.1

—

(3006462) Nitrate [Presence] in Urine

0.00

0.20

0.0

1.9

—

(4211845)

0.00

0.20

0.0

1.9

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

111

0.81

0.20

2.1

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

108

1.21

0.20

13.2

12.5

—

(21494755) Public health laboratory ask at order entry panel

186

0.85

0.19

1.2

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

260

1.12

0.19

3.5

2.4

27.6

30.8

u/l

0.43

211

(3051651) Icteric interference index of Serum or Plasma

1.18

0.19

7.0

4.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

376

1.10

0.19

7.0

7.2

4.8

6.5

umol/l

0.95

313

(3013290) Carbon dioxide [Partial pressure] in Blood

1.21

0.18

3.3

8.0

5.7

4.8

kpa

—

(3027315) Oxygen [Partial pressure] in Blood

1.21

0.18

3.4

8.0

9.2

kpa

—

(3044640) Blood type and Crossmatch panel - Blood

780

0.94

0.17

4.0

3.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

170

1650

1.05

0.17

9.5

6.5

6.2

6.0

mmol/l

0.32

162

1540

(3014051) Protein [Presence] in Urine by Test strip

0.72

0.17

4.2

1.7

—

(3028300) Cannabinoids [Presence] in Urine

486

1.08

0.17

1.3

1.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

585

0.93

0.16

2.3

2.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.20

0.16

1.5

1.7

—

(3013115) Eosinophils [#/volume] in Blood

214

2091

1.05

0.16

9.1

9.6

0.2

e9/l

0.97

184

1792

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1.10

0.15

1.4

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.10

0.15

1.4

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1.10

0.15

1.4

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1.10

0.15

1.4

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

109

1048

1.05

0.15

1.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

197

1.12

0.15

1.2

1.1

12.4

6.6

u/ml

0.53

110

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

410

1.08

0.15

1.3

1.4

1.3

1.4

0.09

373

(4062490)

1.16

0.15

1.3

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

675

0.94

0.15

2.5

2.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.11

0.15

1.0

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1.10

0.15

4.1

4.4

43.8

50.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

223

0.89

0.15

1.9

2.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

237

1.10

0.14

1.7

2.2

12.8

9.0

nmol/l

0.53

183

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.19

0.14

1.2

1.1

0.4

1.6

u/ml

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

255

2508

1.04

0.13

3.9

3.2

14.3

14.4

pmol/l

0.10

230

2236

(3052851) Hemolysis interference index of Serum or Plasma

109

0.82

0.13

5.6

3.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

104

1.16

0.12

2.3

4.4

—

(3000764) Benzodiazepines [Presence] in Urine

483

1.06

0.12

1.3

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

162

1.12

0.12

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

661

1.05

0.11

3.8

3.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

435

1.06

0.11

3.2

2.4

20.7

16.3

ng/l

0.26

148

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

278

2814

0.97

0.11

4.3

3.6

2.0

mu/l

0.12

258

2638

(3007853) Bacteria identified in Skin by Aerobe culture

444

0.94

0.11

2.5

1.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

105

1.15

0.11

1.3

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

136

0.88

0.11

1.1

1.2

—

(3027008) Opiates [Presence] in Urine

486

1.06

0.10

1.3

1.7

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

125

1.12

0.10

12.5

13.8

0.7

0.11

125

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

281

1.07

0.09

2.1

1.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

139

1419

0.97

0.09

1.6

1.7

1.5

g/l

0.24

721

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

106

1033

1.03

0.09

2.8

2.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

292

1.07

0.09

8.5

6.8

2277.1

703.7

ng/l

0.73

245

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.83

0.08

2.2

2.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

0.77

0.08

1.0

1.4

—

184.0

—

(3016018) Differential panel - Cerebral spinal fluid

1.09

0.08

5.6

4.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

117

1.11

0.08

1.8

1.3

—

(3010421) pH of Blood

1.08

0.08

3.4

7.3

7.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

580

0.96

0.07

2.2

1.8

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

179

1815

0.98

0.07

10.4

6.2

110.8

112.1

ml/min/173m2

0.26

117

1149

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.85

0.07

1.6

1.5

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

0.88

0.07

2.4

2.1

0.2

0.1

nmol/l

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.13

0.07

1.3

1.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.84

0.06

1.8

1.4

—

(3000330) Specific gravity of Urine by Test strip

105

0.85

0.06

3.2

2.1

—

(3027944) Amphetamines [Presence] in Urine

483

1.04

0.06

1.3

1.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

345

0.95

0.06

1.2

2.1

10.2

u/ml

—

103

(3035637) Corticotropin [Mass/volume] in Plasma

148

1.08

0.06

1.6

1.8

—

(3044889) 12 lead EKG panel

133

1308

1.02

0.06

2.3

2.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

486

0.96

0.06

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

151

0.92

0.05

1.7

1.9

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

313

0.95

0.05

1.3

1.2

3.0

u/ml

0.01

102

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

100

1.10

0.05

2.2

1.8

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

171

0.93

0.05

1.2

1.1

0.7

u/ml

—

(3000850) Epithelial cells [#/volume] in Urine

715

1.02

0.04

3.9

3.4

7.6

7.3

e6/l

0.07

634

(3003888) Timothy IgE Ab [Units/volume] in Serum

328

1.04

0.04

1.2

8.2

7.2

u/ml

0.11

245

(3023430) Cat dander IgE Ab [Units/volume] in Serum

180

1.06

0.04

1.2

1.1

26.5

10.1

u/ml

0.37

108

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

151

1.06

0.03

1.3

1.4

0.2

g/l

0.42

145

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

201

1.05

0.03

1.3

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

152

1.05

0.02

1.3

1.4

1.2

1.1

g/l

0.31

145

(1001926) Buprenorphine [Presence] in Urine by Screen method

381

1.03

0.02

1.3

1.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

322

1.03

0.01

1.2

0.5

1.1

u/ml

1.28

230

(3048689) Calprotectin [Mass/mass] in Stool

741

1.01

0.01

2.4

3.3

78.5

112.8

ug/g

0.81

577

(3018677) aPTT in Platelet poor plasma by Coagulation assay

527

0.98

0.01

8.8

6.1

32.6

31.0

0.81

520

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

984

1.01

0.00

2.7

2.4

—

(3025941) Bacteria identified in Stool by Culture

167

1.02

0.00

1.4

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

206

1.02

0.00

1.9

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

218

1.01

0.00

1.3

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

363

3632

0.99

0.00

4.0

3.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

348

1.01

0.00

1.3

2.9

3.0

u/ml

0.02

225

(3028707) Methadone [Presence] in Urine by Screen method

228

1.01

0.00

1.2

2.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

133

0.98

0.00

1.5

1.3

—

(3008898) HLA-B27 [Presence]

184

0.98

0.00

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

115

1.04

0.00

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

116

1.03

0.00

1.0

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

143

0.98

0.00

1.4

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

959

1.00

0.00

2.4

2.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

373

0.99

0.00

1.2

8.8

14.9

iu/ml

—

(40768797) Stomach Pathology biopsy report

251

1.00

0.00

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

355

0.98

0.00

1.7

1.2

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

7.8

—

3.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

0.0

1.4

—

(3012565) Volume of 24 hour Urine

0.00

0.0

1.3

—

1737.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.00

0.00

1.3

1.8

211.5

139.7

ng/l

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.0

5.1

—

138.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.92

0.00

1.0

1.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.96

0.00

7.4

6.0

2.0

2.1

ug/l

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

0.93

0.00

9.1

3.1

611.3

335.9

ug/l

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.00

0.0

2.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.00

0.0

2.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.0

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

1.3

—

(4146454)

0.00

0.0

3.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.00

0.0

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.0

—

85.6

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

0.92

0.00

1.0

1.2

100.8

79.4

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.0

1.0

—

305.0

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

0.00

0.0

3.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

0.96

0.00

2.6

1.9

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.0

1.0

—

(40768443) Skin Pathology biopsy report

0.97

0.00

1.4

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(3021901) Oxygen saturation in Capillary blood

0.90

0.00

5.1

7.8

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

2.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(40757373) Influenza virus identified in Isolate

0.00

0.0

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.97

0.00

1.0

1.6

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

0.94

0.00

1.0

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.88

0.00

1.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.94

0.00

1.6

1.3

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.99

0.00

4.1

4.0

2.6

3.3

e9/l

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

2.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.00

0.00

1.3

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.97

0.00

2.8

2.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.0

1.2

—

(4198724)

0.91

0.00

1.5

1.6

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

1.01

0.00

2.0

3.6

—

717.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.96

0.00

1.0

1.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(3042517) Benzodiazepines panel - Urine

0.00

0.0

4.0

—

(40763791) Oxygen content in Venous blood by calculation

0.00

-0.00

0.0

22.0

—

13.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

-0.00

0.0

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

-0.00

0.0

20.0

—

(3017509) Phencyclidine [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.5

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

75.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

-0.00

0.0

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

-0.00

0.0

1.2

—

(3016228) CD19 cells/100 cells in Blood

0.00

-0.00

0.0

3.5

—

13.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

0.00

-0.00

0.0

3.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint P16_INFECTIONS_SPECIFIC_PERINA_PERIOD and mortality.

Females

Parameter	HR [95% CI]	p-value
P16_INFECTIONS_SPECIFIC_PERINA_PERIOD	1.84 [1.45, 2.34]	< 0.001
Birth year	0.998 [0.99, 1.01]	0.613

During the follow-up period (1.1.1998 — 31.12.2019), 79 out of 16734 females with P16_INFECTIONS_SPECIFIC_PERINA_PERIOD died.

Males

Parameter	HR [95% CI]	p-value
P16_INFECTIONS_SPECIFIC_PERINA_PERIOD	1.099 [0.9, 1.34]	0.351
Birth year	0.987 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 113 out of 23642 males with P16_INFECTIONS_SPECIFIC_PERINA_PERIOD died.

Mortality risk

Mortality risk for people of age

years, who have P16_INFECTIONS_SPECIFIC_PERINA_PERIOD.

N-year risk	Females	Males
1	0.158%	0.199%
5	1.081%	1.32%
10	2.695%	3.159%
15	5.399%	6.062%
20	9.582%	10.507%

Relationships between endpoints

↥

Index endpoint: P16_INFECTIONS_SPECIFIC_PERINA_PERIOD – Infections specific to the perinatal period

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Infections specific to the perinatal period

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints